126 related articles for article (PubMed ID: 30949459)
21. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
[TBL] [Abstract][Full Text] [Related]
23. Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
Ecker BL; Hoteit MA; Forde KA; Hsu CC; Reddy KR; Furth EE; Siegelman ES; Habibollahi P; Ben-Josef E; Porrett PM; Abt PL; Shaked A; Olthoff KM; Levine MH
Transplantation; 2018 Apr; 102(4):648-655. PubMed ID: 29319629
[TBL] [Abstract][Full Text] [Related]
24. UCSF criteria by pre-transplant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria.
Ju MK; Choi GH; Huh KH; Joo DJ; Kim SJ; Choi J; Kim MS; Kim SI; Kim YS
Hepatogastroenterology; 2010; 57(101):819-25. PubMed ID: 21033236
[TBL] [Abstract][Full Text] [Related]
25. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
[TBL] [Abstract][Full Text] [Related]
27. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Kim HD; Shim JH; Kim GA; Shin YM; Yu E; Lee SG; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Hepatol; 2015 May; 62(5):1076-84. PubMed ID: 25529626
[TBL] [Abstract][Full Text] [Related]
28. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
Sharr WW; Chan SC; Lo CM
Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
[TBL] [Abstract][Full Text] [Related]
30. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
31. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
Abdelfattah MR; Elsiesy H; Al-Manea H; Broering DC
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):398-403. PubMed ID: 29280920
[TBL] [Abstract][Full Text] [Related]
34. Transplantation for Hepatocellular Carcinoma: Is There a Tumor Size Limit?
Daoud A; Teeter L; Ghobrial RM; Graviss EA; Mogawer S; Sholkamy A; El-Shazli M; Gaber AO
Transplant Proc; 2018 Dec; 50(10):3577-3581. PubMed ID: 30577241
[TBL] [Abstract][Full Text] [Related]
35. Addition of alfa fetoprotein to traditional criteria for hepatocellular carcinoma improves selection accuracy in liver transplantation.
Sternby Eilard M; Holmberg E; Naredi P; Söderdahl G; Rizell M
Scand J Gastroenterol; 2018 Aug; 53(8):976-983. PubMed ID: 30169974
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation for patients with hepatocellular carcinoma.
Ho MC; Wu YM; Hu RH; Ko WJ; Yang PM; Lai MY; Lin MH; Lin HY; Lee PH
Transplant Proc; 2004 Oct; 36(8):2291-2. PubMed ID: 15561223
[TBL] [Abstract][Full Text] [Related]
37. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
[TBL] [Abstract][Full Text] [Related]
39. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]